Skip to main content

Table 2 ᅟ

From: Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries

  Total number of medicines for CVDs Thiazide diuretics Selective β1 blockers Dihydropyridine CCBs RAAS inhibitors## Statins ADP receptor inhibitors## Thrombolytic agents Long-acting nitrates Non-dihydropyridine CCBs## Heparin-like medicines Loop diuretics Aldosterone antagonists Digitalis glycosides Oral anticoagulants Pharmacological cardioversion Medicines for maintaining sinus rhythm
Overall 24 (16-50) 1 (0-2) 1 (1-5) 2 (1-4) 2(1-11) 1(0-4) 0(0-2) 1(0-2) 1(0-2) 1(0-3) 1(1-4) 1(1-2) 1(1-1) 1(1-2) 1(0-2) 1(0-3) 1(0-4)
Low income(n = 6) 19.5(16-24) 1(1-2) 1(1-2) 2(1-3) 2(1-2) 0.5(0-2) 0(0-0) 0.5(0-2) 1(0-1) 1(0-1) 1(1-2) 1(1-2) 1(1-1) 1(1-2) 1(0-2) 0.5(0-1) 0.5(0-1)
Lower middle income (n = 11) 20(16-44) 1(1-2) 1(1-3) 2(1-3) 2(1-6) 1(0-4) 0(0-2) 1(0-2) 1(1-2) 1(1-2) 1(1-4) 1(1-2) 1(1-1) 1(1-1) 1(1-2) 1(0-3) 1(0-4)
Upper middle income (n = 17) 25(17-50) 1(0-2) 2(1-5) 2(1-4) 2(1-11) 1(0-4) 1(0-2) 1(0-2) 1(1-2) 2(0-3) 2(1-3) 1(1-2) 1(1-1) 1(1-2) 1(0-2) 1(0-3) 1(0-3)
p-value* 0.014 0.258 0.167 0.824 0.080 0.194 0.087 0.547 0.013 0.001 0.542 0.901 1.000 0.133 0.701 0.052 0.043
AMRO(n = 9) 32(20-39) 1(0-2) 2(1-3) 2(1-4) 3(2-7) 2(1-4) 1(0-1) 1(0-2) 2(1-2) 2(1-3) 2(1-4) 1(1-1) 1(1-1) 1(1-2) 1(1-2) 1(1-3) 1(1-3)
AFRO(n = 9) 20(16-44) 1(0-2) 1(1-3) 2(1-3) 2(1-6) 0(0-4) 0(0-2) 1(0-2) 1(0-1) 1(0-2) 1(1-2) 1(1-2) 1(1-1) 1(1-2) 1(1-2) 1(0-3) 1(0-4)
WPRO(n = 7) 21(16-26) 1(1-2) 1(1-3) 1(1-2) 2(2-2) 1(0-1) 0(0-1) 1(0-1) 1(1-2) 1(0-3) 1(1-2) 1(1-1) 1(1-1) 1(1-2) 1(0-1) 1(0-2) 1(0-2)
SEARO(n = 5) 27(20-35) 1(1-2) 2(1-3) 2(1-2) 2(1-3) 1(1-1) 1(1-2) 1.5(1-2) 1.5(1-2) 1.5(1-2) 2(2-3) 1(1-1) 1(1-1) 1(1-1) 1(1-1) 1(1-3) 1(1-3)
EMRO(n = 4) 22(18-50) 1(1-1) 2(1-5) 2.5(1-4) 3(1-11) 1(1-4) 0(0-2) 1(0-2) 1(1-1) 1(1-2) 2(1-3) 1(1-2) 1(1-1) 1(1-1) 1(0-1) 0.5(0-3) 0.5(0-3)
p-value** 0.049 0.833 0.204 0.205 0.013 0.033 0.059 0.255 0.011 0.379 0.029 0.138 1.000 0.746 0.118 0.241 0.192
WHO # 21 1$ 1$ 1$ 1$ 1$ 1 1 1$ 1 2$ 1 1 1 1$ 1 1